Remove Clinical Trials Remove Document Remove Legalization Remove Patients
article thumbnail

European Regulatory Lead MAPS PBC Santa Cruz, CA

Cannabis Law Report

The results of our successful pivotal Phase 3 clinical trial were recently published in Nature Medicine and profiled on the front page of The New York Times. Ensure high quality, timely, and consistent submission of regulatory documents. Why work for MAPS Public Benefit Corporation (MAPS PBC)? Key Responsibilities.

article thumbnail

Meredith Fisher-Corn, MD…….”Are You Able to Answer Your Patients’ Medical Marijuana Questions”

TheAnswerPage

Are you able to answer your patients’ medical marijuana questions? and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ million medical marijuana patients nationwide. Written by Dr. Meredith Fisher-Corn, MD , Editor-in-Chief at TheAnswerPage.com.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Today’s Answer of the Day

TheAnswerPage

According to the Controlled Substances Act, is it legal to transport marijuana across state lines from one medical marijuana legal state to another medical marijuana legal state? ” See Answer.

article thumbnail

MAPS – Position: European Regulatory Lead

Cannabis Law Report

The results of our successful pivotal Phase 3 clinical trial were recently published in Nature Medicine and profiled on the front page of The New York Times. Ensure high quality, timely, and consistent submission of regulatory documents. Why work for MAPS Public Benefit Corporation (MAPS PBC)? Key Responsibilities.

article thumbnail

MMJ Laws In Texas: Your Complete Guide

MMJ Recs

Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals. Physician’s Prescription: Patients must obtain a prescription from a qualified physician registered with the TCUP.

Law 52
article thumbnail

AIMS v. Garland: A Disappointment for Psilocybin Advocates, but Progressive Policy May Still be on the Horizon

Cannabis Law Report

Court of Appeals for the Ninth Circuit dismissed a petition for review of a Drug Enforcement Administration (DEA) response to an attorney’s letter seeking advice and guidance on how a physician could administer psilocybin to a terminally ill patient without incurring liability under the Controlled Substances Act (CSA).

DEA 52
article thumbnail

Position: European Regulatory Lead – Remote MAPS PBC California Remote

Cannabis Law Report

It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine or profiled on the front page of The New York Times. Ensure high quality, timely, and consistent submission of regulatory documents. European Regulatory Lead Executive Summary.